Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Rang in Aktien #28133
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Aktienkurs
$0.37430781
Zuletzt synchronisiert: 2026-08-19
Marktkapitalisierung
$28.37M
Veränderung (1 Tag)
2.00%
Veränderung (1 Jahr)
-13.46%
Land
CA
Handel Defence Therapeutics Inc. (DTC)

Kategorie

Preis DTC mit Marktkapitalisierung von B
Defence Therapeutics Inc. Defence Therapeutics Inc.
DTC
$0.37430781
Marktkapitalisierung von Defence Therapeutics Inc.(DTC)
Marktkapitalisierung: $28.37M
Mit Stand August 2026 hat Defence Therapeutics Inc. eine Marktkapitalisierung von $28.37M. Das macht Defence Therapeutics Inc. laut unseren Daten zum 28133rd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Defence Therapeutics Inc. von 2021 bis 2026
DTC im Vergleich zu den Top 5 der beliebtesten stocks
Preis für DTC Vermögenswert B Marktkapitalisierung von B Ergebnisse
Defence Therapeutics Inc. Defence Therapeutics Inc.
$69,938.64 $28.37M
$5.301T +18,684,692.99%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$61,138.37 $28.37M
$4.634T +16,333,614.82%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$54,661.70 $28.37M
$4.143T +14,603,308.09%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$47,357.50 $28.37M
$3.589T +12,651,919.85%
Defence Therapeutics Inc. Defence Therapeutics Inc.
$37,694.03 $28.37M
$2.857T +10,070,230.74%